gemcitabine has been researched along with Spinal Cord Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harrington, C; James, M; Wynne, C | 1 |
| Barstis, JL; Black, AC | 1 |
2 other study(ies) available for gemcitabine and Spinal Cord Diseases
| Article | Year |
|---|---|
Radiation myelopathy after 36 Gy in 12 fractions palliative chest radiotherapy for squamous cell cancer of the lung: case report and review of published studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Deoxycytidine; Dose Fractionation, Radiation; Fatal Outcome; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Palliative Care; Radiation Injuries; Radiotherapy; Radiotherapy Dosage; Spinal Cord; Spinal Cord Diseases; Thorax; Tomography, X-Ray Computed | 2010 |
Myelopathy after radiation therapy and chemotherapy with capecitabine and gemcitabine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Combined Modality Therapy; Deoxycytidine; Female; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Middle Aged; Radiation Injuries; Radiation-Sensitizing Agents; Spinal Cord Diseases | 2005 |